Describe long-term control and quick relief treatment options for the asthma patient from your practice as well as the impact these drugs might have on your patient.

Describe long-term control and quick relief treatment options for the asthma patient from your practice as well as the impact these drugs might have on your patient.

Describe long-term control and quick relief treatment options for the asthma patient from your practice as well as the impact these drugs might have on your patient. 150 150 Nyagu

Asthma and Stepwise Management PowerPoint
Asthma and Stepwise Management PowerPoint

Long-term Control Options for Asthma Patients

Work over time to:

Stop symptoms

Reduce airways swelling

Relax the muscle bands around airways

Long-term control medications include

Anti-inflammatory drugs

Bronchodilators

ORDER A PLAGIARISM-FREE PAPER HERE

Anti-inflammatory drugs:

Prevent asthmatic symptoms

Reduce swelling in the airways in case of a trigger

Control mucus in to ease breathing

Long-term Control Options for Asthma Patients Cont.

Examples of anti-inflammatory drugs are:

Inhaled corticosteroids

uCromolyn sodium

Montelukast

Zafirlukast

Zileuton

Bronchodilators taken together with anti-inflammatory drugs to:

Ease breathing by relaxing muscles around airways

Asthma and Stepwise Management PowerPoint

Examples of bronchodilators:

uInhaled long-acting beta2-agonists

uCombination inhalers

uTheophylline

uQuick Relief Treatment Options for Asthma Patients

uUsed to rapidly relieve flaring asthma symptoms

uWork by:

uLoosening tight muscles around airways to allow air to flow

uRapidly relaxes airways to ease breathing

uRelieves swelling in the airways

uExamples of short-term asthma treatments:

uInhaled short-acting beta2 agonists

uIpratropium (Atrovent)

uCorticosteroids.

u

uLong-term Effects of Asthma Medications

uEffects of corticosteroids include:

uDermal thinning

uDiabetes

uHigh blood pressure

uGrowth suppression

uEffects of inhaled long-acting beta2-agonists are:

uIncreased heart rate

uHypokalemia

uShakiness

uThe Stepwise Approach to Asthma Treatment and Management

u1st step: Mild intermittent symptoms & recommended drugs are short-acting beta-agonist like albuterol prn

u2nd step: Mild persistent asthma & drugs are low-dose inhaled corticosteroids & alternatively leukotriene blocker or cromolyn

u3rd & 4th steps: Moderate & severe asthma. The dose of inhaled corticosteroid is either increased or LABA added or both for step 4

u5th & 6th steps: Dose of inhaled corticosteroids is further increased & omalizumab can be added. In 6th step, oral/chronic corticosteroids are considered

uImportance of stepwise management to health care providers & patients

uProvides written action plans to guide patients how to control of asthmatic attack or exacerbations

uAllows providers to develop patient-tailored treatment plans

uAllows prompt management of any change in patient’s condition

uAdjusting drugs stepwise helps patients to gain & maintain control of the disease proces

uReferences

uEfraij K & Mark F. (2015). Current and emerging treatments for severe asthma. J Thorac Dis. 7(11), E522–E525.

uHorak F, Daniel D, Eber E, Horak E, Pohl W, osef R, et al. (2016). Diagnosis and management of asthma – Statement on the 2015 GINA Guidelines. Wien Klin Wochenschr. 128(15), 541–554.

uAnise A & Romana H. (2016). Patient-centered outcomes research to improve asthma outcomes. Clinical reviews in allergy and immunology. 138(6), 1503–1510.

uReddel H, Eric B, Becker A, Cruz A, Drazen J et al. (2015). A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J. 46(3), 622–639.

Reflect on drugs used to treat asthmatic patients, including long-term control and quick relief treatment options for patients. Think about the impact these drugs might have on patients, including adults and children.
Consider how you might apply the stepwise approach to address the health needs of a patient in your practice.
Reflect on how stepwise management assists health care providers and patients in gaining and maintaining control of the disease.

Create a 5- to 6-slide PowerPoint presentation that can be used in a staff development meeting on presenting different approaches for implementing the stepwise approach for asthma treatment. Be sure to address the following: Asthma and Stepwise Management PowerPoint

ASSIGNMENT:
Describe long-term control and quick relief treatment options for the asthma patient from your practice as well as the impact these drugs might have on your patient.
Explain the stepwise approach to asthma treatment and management for your patient.
Explain how stepwise management assists health care providers and patients in gaining and maintaining control of the disease. Be specific.

RUBRIC:
Describe the long-term control and quick relief treatment options for the asthma patient from your practice, as well as the impact these drugs might have on your patient. Asthma and Stepwise Management PowerPoint
Explain the stepwise approach to asthma treatment and management for your patient.
Explain how stepwise management assists health care providers and patients in gaining and maintaining control of the disease. Be specific.
Written Expression and Formatting – Paragraph Development and Organization:
Paragraphs make clear points that support well developed ideas, flow logically, and demonstrate continuity of ideas. Sentences are carefully focused–neither long and rambling nor short and lacking substance.
Written Expression and Formatting – English writing standards:
Correct grammar, mechanics, and proper punctuation Asthma and Stepwise Management PowerPoint

uAsthma and Stepwise Management

uLong-term Control Options for Asthma Patients

uWork over time to:

uStop symptoms

uReduce airways swelling

uRelax the muscle bands around airways

uLong-term control medications include

uAnti-inflammatory drugs

uBronchodilators

uAnti-inflammatory drugs:

uPrevent asthmatic symptoms

uReduce swelling in the airways in case of a trigger

Asthma and Stepwise Management PowerPoint

uControl mucus in to ease breathing

uLong-term Control Options for Asthma Patients Cont.

uExamples of anti-inflammatory drugs are:

uInhaled corticosteroids

uCromolyn sodium

uMontelukast

uZafirlukast

uZileuton

uBronchodilators taken together with anti-inflammatory drugs to:

uEase breathing by relaxing muscles around airways

Asthma and Stepwise Management PowerPoint

uExamples of bronchodilators:

uInhaled long-acting beta2-agonists

uCombination inhalers

uTheophylline

uQuick Relief Treatment Options for Asthma Patients

uUsed to rapidly relieve flaring asthma symptoms

uWork by:

uLoosening tight muscles around airways to allow air to flow

uRapidly relaxes airways to ease breathing

uRelieves swelling in the airways

uExamples of short-term asthma treatments:

uInhaled short-acting beta2 agonists

uIpratropium (Atrovent)

uCorticosteroids.

u

uLong-term Effects of Asthma Medications

uEffects of corticosteroids include:

uDermal thinning

uDiabetes

uHigh blood pressure

uGrowth suppression

uEffects of inhaled long-acting beta2-agonists are:

Asthma and Stepwise Management PowerPoint

uIncreased heart rate

uHypokalemia

uShakiness

uThe Stepwise Approach to Asthma Treatment and Management

u1st step: Mild intermittent symptoms & recommended drugs are short-acting beta-agonist like albuterol prn

u2nd step: Mild persistent asthma & drugs are low-dose inhaled corticosteroids & alternatively leukotriene blocker or cromolyn

u3rd & 4th steps: Moderate & severe asthma. The dose of inhaled corticosteroid is either increased or LABA added or both for step 4

u5th & 6th steps: Dose of inhaled corticosteroids is further increased & omalizumab can be added. In 6th step, oral/chronic corticosteroids are considered

uImportance of stepwise management to health care providers & patients

uProvides written action plans to guide patients how to control of asthmatic attack or exacerbations

uAllows providers to develop patient-tailored treatment plans

uAllows prompt management of any change in patient’s condition

uAdjusting drugs stepwise helps patients to gain & maintain control of the disease proces

uReferences

uEfraij K & Mark F. (2015). Current and emerging treatments for severe asthma. J Thorac Dis. 7(11), E522–E525.

uHorak F, Daniel D, Eber E, Horak E, Pohl W, osef R, et al. (2016). Diagnosis and management of asthma – Statement on the 2015 GINA Guidelines. Wien Klin Wochenschr. 128(15), 541–554.

uAnise A & Romana H. (2016). Patient-centered outcomes research to improve asthma outcomes. Clinical reviews in allergy and immunology. 138(6), 1503–1510.

uReddel H, Eric B, Becker A, Cruz A, Drazen J et al. (2015). A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J. 46(3), 622–639.

u